Despite major changes in the prevalence of antibiotic resistance, the 2011 IDSA guideline for uncomplicated UTI still accurately reflects the efficacy and safety of first-line treatments.
It’s important to address recurring and chronic sinusitis, even if you already take medications for asthma. Healthline has strict sourcing guidelines and relies on peer-reviewed studies ...
In a move to expand its portfolio beyond antibiotics, Paratek Pharmaceuticals has bought out Optinose and its chronic rhinosinusitis (CRS) nasal spray Xhance for up to $330 million. Triggering the ...
I’m beginning to wonder if my symptoms are really from allergies or if they may be caused by a sinus infection instead. How can I tell the difference? Answer: Allergies and sinus infections ...
Already billed as a potential blockbuster, Amgen and AstraZeneca’s Tezspire has turned in strong clinical data in chronic rhinosinusitis with nasal polyps (CRSwNP). Tezspire showed numerically ...
Acadiana Allergy Center’s Dr. Bradley Chastant advises that if allergy symptoms persist despite over-the-counter treatments, ...
Different RTIs were analysed separately, and this paper focuses on patients with acute sinusitis. Methods, design and patients: This was an open-label, prospective, uncontrolled, post-marketing ...
The prevalence of chronic sinusitis in China is about 8 percent, meaning it affects approximately 107 million people, according to official estimates. Chronic sinusitis with nasal polyps (CRSwNP ...
The Kidney Disease: Improving Global Outcomes organization's updates to its 2024 guidelines expand SGLT2 inhibitor use and refine chronic kidney disease (CKD) management. The Kidney Disease ...
Dr. Ransom is a graduate of the University of Iowa College of Medicine (1962) and was certified by the American Board of Allergy and Immunology in 1974. He is a Fellow of the American College of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results